A retrospective study evaluating influence of ALK variants on the disease outcomes in patinets treated with ALK tyrosine kinase inhibitors for non-small cell lung cancer
Latest Information Update: 08 Jan 2019
At a glance
- Drugs Alectinib (Primary) ; Ceritinib (Primary) ; Crizotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 08 Jan 2019 New trial record